|
U2AF2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30260024988615E-10 |
| Normal-vs-Stage2 |
2.43450000003698E-06 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.8849000000063E-05 |
| Stage1-vs-Stage2 |
5.174800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
6.127800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.187800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
9.8897001699072E-11 |
| Normal-vs-Asian |
1.18679954752565E-10 |
| Caucasian-vs-AfricanAmerican |
1.509650E-02 |
| Caucasian-vs-Asian |
4.587000E-01 |
| AfricanAmerican-vs-Asian |
2.303500E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32820001850365E-09 |
| Normal-vs-Female |
2.68673971959288E-14 |
| Male-vs-Female |
7.608400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.09390000000176E-06 |
| Normal-vs-Extreme_Weight |
1.47080003731759E-09 |
| Normal-vs-Obese |
1.0766000000384E-06 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
1.519210E-01 |
| Normal_Weight-vs-Obese |
2.037700E-03 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
7.688200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70790004361265E-09 |
| Normal-vs-Age(41-60Yrs) |
2.05450000012597E-07 |
| Normal-vs-Age(61-80Yrs) |
2.60902410786912E-14 |
| Normal-vs-Age(81-100Yrs) |
3.839200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.705000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.619600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.175400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.596200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.719600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.764800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
3.006600E-01 |
| Normal-vs-Grade 3 |
9.026000E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
1.570610E-01 |
| Grade 2-vs-Grade 4 |
3.006600E-01 |
| Grade 3-vs-Grade 4 |
9.026000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63513647066793E-12 |
| Normal-vs-N1 |
5.5199999999922E-05 |
| N0-vs-N1 |
5.709600E-01 |
|
|
